# Advantest Controls 70% of AI Chip Testing — Up 450% in a Year — and Whether the Valuation Still Makes Sense

Page: https://stenobird.com/podcast/chip-stock-investor-podcast-6441813/advantest-controls-70-of-ai-chip-testing-up-450-in-a-year-and-whether-the-valuation-still-makes-sense
Text version: https://stenobird.com/podcast/chip-stock-investor-podcast-6441813/advantest-controls-70-of-ai-chip-testing-up-450-in-a-year-and-whether-the-valuation-still-makes-sense.md
Podcast: [Chip Stock Investor Podcast](https://stenobird.com/podcast/chip-stock-investor-podcast-6441813)
Published: 2026-05-01T13:00:01+00:00
Episode link: https://podcasters.spotify.com/pod/show/chipstockinvestor/episodes/Advantest-Controls-70-of-AI-Chip-Testing--Up-450-in-a-Year--and-Whether-the-Valuation-Still-Makes-Sense-e3io491
Audio file: https://anchor.fm/s/e2cacf78/podcast/play/119328481/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-1%2F423256196-44100-2-3eb668819b96a.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/chip-stock-investor-podcast-6441813/episodes/advantest-controls-70-of-ai-chip-testing-up-450-in-a-year-and-whether-the-valuation-still-makes-sense
Duration seconds: 618

## Resource

Many investors were not aware of Advantest. This Japanese company quietly controls roughly 70% of the global semiconductor test equipment market — the quality assurance layer that every AI chip, every HBM memory module, and every packaged GPU must pass through before it ships to a customer. As AI chips have gotten more complex and more expensive, the cost of shipping a faulty one has risen dramatically, and the demand for Advantest's equipment has followed. The stock reflects that. Up 450% in the past year. Up roughly 250% since CSI first wrote about Advantest eleven months ago. Analyst earnings per share expectations have roughly doubled in twelve months — that is what drove the run. Advantest just reported FY2025 results of $7.1 billion in revenue and guided FY2026 to approximately $9 billion, a 26% year-over-year increase. In a test equipment market the company itself sizes at $12.5 to $13 billion for 2026, that would put Advantest's global market share approaching 70% — a level of dominance that is genuinely rare in any industry. Nick and Kasey cover the full picture in CSI's first public video on Advantest: how it became the undisputed leader, why the test equipment slice of the $140 billion wafer fab equipment market is small but critical, what the 47x forward earnings and 56x forward free cash flow multiples actually imply, and why some analysts are already flagging a potential cycle downturn starting in 2027 even as the bulls hold firm. The close is pure CSI. Radical moderation. Patience is a strategy. Stay in the game and survive. What we cover: — Advantest FY2025: $7.1B revenue and dominant market share vs. Teradyne and Aehr — FY2026 guidance: ~$9B — approaching 70% of a $12.5–13B global TAM — Why AI chips and packaged modules require testing — and why it is…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/chip-stock-investor-podcast-6441813/episodes/advantest-controls-70-of-ai-chip-testing-up-450-in-a-year-and-whether-the-valuation-still-makes-sense/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/chip-stock-investor-podcast-6441813/advantest-controls-70-of-ai-chip-testing-up-450-in-a-year-and-whether-the-valuation-still-makes-sense.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.